» Articles » PMID: 37108373

Differences in Bacterial Small RNAs in Stool Samples from Hypercholesterolemic and Normocholesterolemic Subjects

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Apr 28
PMID 37108373
Authors
Affiliations
Soon will be listed here.
Abstract

Cholesterol metabolism is important at the physiological level as well as in several diseases, with small RNA being an element to consider in terms of its epigenetic control. Thus, the aim of this study was to identify differences between bacterial small RNAs present at the gut level in hypercholesterolemic and normocholesterolemic individuals. Twenty stool samples were collected from hypercholesterolemic and normocholesterolemic subjects. RNA extraction and small RNA sequencing were performed, followed by bioinformatics analyses with BrumiR, Bowtie 2, BLASTn, DESeq2, and IntaRNA, after the filtering of the reads with fastp. In addition, the prediction of secondary structures was obtained with RNAfold WebServer. Most of the small RNAs were of bacterial origin and presented a greater number of readings in normocholesterolemic participants. The upregulation of small RNA ID 2909606 associated with (family ) was presented in hypercholesterolemic subjects. In addition, a positive correlation was established between small RNA ID 2149569 from the species and hypercholesterolemic subjects. Other bacterial and archaeal small RNAs that interacted with the LDL receptor (LDLR) were identified. For these sequences, the prediction of secondary structures was also obtained. There were significant differences in bacterial small RNAs associated with cholesterol metabolism in hypercholesterolemic and normocholesterolemic participants.

Citing Articles

The causal relationship between gut microbiota and lower extremity deep vein thrombosis combined with pulmonary embolism.

Xu Q, Fang J, Wang Y, Lang D, Xu B Front Microbiol. 2024; 15:1301737.

PMID: 39417077 PMC: 11480004. DOI: 10.3389/fmicb.2024.1301737.


Gut Microbiota Dysbiosis, Oxidative Stress, Inflammation, and Epigenetic Alterations in Metabolic Diseases.

Mostafavi Abdolmaleky H, Zhou J Antioxidants (Basel). 2024; 13(8).

PMID: 39199231 PMC: 11351922. DOI: 10.3390/antiox13080985.

References
1.
El-Mogy M, Lam B, Haj-Ahmad T, McGowan S, Yu D, Nosal L . Diversity and signature of small RNA in different bodily fluids using next generation sequencing. BMC Genomics. 2018; 19(1):408. PMC: 5975555. DOI: 10.1186/s12864-018-4785-8. View

2.
Hosomi K, Saito M, Park J, Murakami H, Shibata N, Ando M . Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota. Nat Commun. 2022; 13(1):4477. PMC: 9388534. DOI: 10.1038/s41467-022-32015-7. View

3.
Chen S, Zhou Y, Chen Y, Gu J . fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018; 34(17):i884-i890. PMC: 6129281. DOI: 10.1093/bioinformatics/bty560. View

4.
Khan S, Naz A, Masood M, Shah R . Meta-Analysis of Inclisiran for the Treatment of Hypercholesterolemia. Am J Cardiol. 2020; 134:69-73. DOI: 10.1016/j.amjcard.2020.08.018. View

5.
Kim M, Huda M, Bennett B . Sequence meets function-microbiota and cardiovascular disease. Cardiovasc Res. 2021; 118(2):399-412. PMC: 8803075. DOI: 10.1093/cvr/cvab030. View